However, the frequency of EGFR expression shown in the present data was inconsistent with another study stating that EGFR amplification was identified in 40–50% of glioblastomas and ∼10% of anaplastic astrocytomas, but not in low-grade astrocytomas (19). The gene discussed is EGFR; the disease is glioblastoma.